SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNIT
Deciphera Pharmaceuticals, Inc. (DCPH)
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
deciphera.com/investor-relations
Company Research
Source: GlobeNewswire
NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)’s sale to ONO Pharmaceutical Co., Ltd. for $25.60 per share in cash. If you are a Deciphera shareholder, click here to learn more about your rights and options. Heartland Financial, USA Inc. (NASDAQ: HTLF)’s sale to UMB Financial Corporation for 0.55 shares of UMB common stock for each share of Heartland common stock. Upon completion of the proposed transaction, former Heartland stockholders are expected to collectively represent approximately 31% of the combined company. If you are a Heartland shareholder, click here to learn more about your rights and options. DecisionPoint Systems, Inc. (NYSE: DPSI)’s sale to an affiliate of Barcoding Holdings, LLC for $10.22 in cash per share. If yo
Show less
Read more
Impact Snapshot
Event Time:
DCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCPH alerts
High impacting Deciphera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
DCPH
News
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPHPR Newswire
- Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates Fri, May 10, 2024, 2:50 PM GMT+2 3 min read 0 In this article: Advertisement Up next Analyst adjusts Nvidia stock price target ahead of earnings Fri, May 10, 2024, 1:03 AM GMAcquire Media Monitor
- Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Weiss Law Investigates Deciphera Pharmaceuticals, Inc.Accesswire
- Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLFAccesswire
DCPH
Earnings
- 5/10/24 - Beat
DCPH
Sec Filings
- 5/13/24 - Form SC
- 5/13/24 - Form SC
- 5/10/24 - Form 10-Q
- DCPH's page on the SEC website